skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Index

Are drug companies living up to their human rights responsibilities? Moving toward assessment

Gruskin, Sofia ; Raad, Zyde

PLoS medicine, 28 September 2010, Vol.7(9), pp.e1000310 [Peer Reviewed Journal]

Full text available

Citations Cited by
  • Title:
    Are drug companies living up to their human rights responsibilities? Moving toward assessment
  • Author: Gruskin, Sofia ; Raad, Zyde
  • Description: The human rights responsibilities of drug companies have been considered for years by nongovernmental organizations, but were most sharply defined in a report by the UN Special Rapporteur on the right to health, submitted to the United Nations General Assembly in August 2008. The "Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicines" include responsibilities for transparency, management, monitoring and accountability, pricing, and ethical marketing, and against lobbying for more protection in intellectual property laws, applying for patents for trivial modifications of existing medicines, inappropriate drug promotion, and excessive pricing. Two years after the release of the Guidelines, the PLoS Medicine Debate asks whether drug companies are living up to their human rights responsibilities. Sofia Gruskin and Zyde Raad from the Harvard School of Public Health say more assessment is needed of such responsibilities; Geralyn Ritter, Vice President of Global...
  • Is Part Of: PLoS medicine, 28 September 2010, Vol.7(9), pp.e1000310
  • Identifier: E-ISSN: 1549-1676 ; PMID: 20927356 Version:1 ; DOI: 10.1371/journal.pmed.1000310
  • Subjects: Human Rights ; Drug Industry -- Ethics
  • Language: English
  • Source: MEDLINE/PubMed (U.S. National Library of Medicine)

Searching Remote Databases, Please Wait